Progress in the treatment of chronic lymphocytic leukemia: results of the German CLL8 trial.

Abstract

Until now, no approach that is able to improve overall survival of chronic lymphocytic leukemia (CLL) patients has been available. In the German CLL Study Group (GCLLSG) CLL8 trial, treatment-naive, physically fit patients (aged 30-81 years) with CD20(+) CLL were randomly assigned in a one-to-one ratio to receive six courses of intravenous fludarabine (25… (More)
DOI: 10.1586/era.11.118

Topics

5 Figures and Tables

Cite this paper

@article{Molica2011ProgressIT, title={Progress in the treatment of chronic lymphocytic leukemia: results of the German CLL8 trial.}, author={Stefano Molica}, journal={Expert review of anticancer therapy}, year={2011}, volume={11 9}, pages={1333-40} }